Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly’s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks with Bloomberg's Dani Burger. 

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly&rsquo;s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks with Bloomberg's Dani Burger.&nbsp;

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novo's Martin Holst Lange Talks New Weight Loss Shot

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/55950a5c-8908-4f1c-a819-b3fa01192054/transcript

Republican US Representative from Missouri Jason Smith speaks on the Supreme Court's decision to strike down President Trump's global tariffs and what this means for fiscal policy. He speaks with Bloomberg's Dani Burger. 

Republican US Representative from Missouri Jason Smith speaks on the Supreme Court's decision to strike down President Trump's global tariffs and what this means for fiscal policy. He speaks with Bloomberg's Dani Burger.&nbsp;

Rep. Jason Smith Talks Tariffs, Trade Uncertainty

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/2842e3d3-7e5b-4857-8703-b3fa01192054/transcript

MTA CEO Janno Lieber provides key details on updates about the blizzard that affected the NYC area and how the city set up preparations for it. He speaks with Bloomberg's Tom Keene and Paul Sweeney

MTA CEO Janno Lieber provides key details on updates about the blizzard that affected the NYC area and how the city set up preparations for it. He speaks with Bloomberg's Tom Keene and Paul Sweeney

MTA CEO Janno Lieber Talks NYC Blizzard

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b7df11c4-bc9d-4b2e-bfbd-b3fa01159da6/transcript

Raoul Ruparel, director of Boston Consulting Group's Centre for Growth, discusses his research showing Britain’s biggest industries have been responsible for the decades-long decline in productivity that has roughly halved the GDP growth rate since the end of the 1990s. He spoke to Stephen Carroll and Caroline Hepker on Bloomberg Daybreak Europe.

Raoul Ruparel, director of Boston Consulting Group's Centre for Growth, discusses his research showing Britain&rsquo;s biggest industries have been responsible for the decades-long decline in productivity that has roughly halved the GDP growth rate since the end of the 1990s. He spoke to Stephen Carroll and Caroline Hepker on Bloomberg Daybreak Europe.

BCG's Raoul Ruparel Talks UK Productivity

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/232f6191-e385-48c9-a924-b3fa00c1f9a4/transcript

Novo's Martin Holst Lange Talks New Weight Loss Shot

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips